Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ocrelizumab in Class III/IV Lupus Nephritis
2006-005357-29Phase 3Completed
- Sponsor
- Roche
- Start
- Aug 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of ocrelizumab in lupus nephritis (LN), sponsored by Roche. Started Aug 2007; status: completed.
02
Drugs
ocrelizumab
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on 2006-005357-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005357-29.